 

Active ingredient: Bethanechol Chloride 

 

Form/Route: Tablet/Oral 

 

Recommended studies: 

 

Bethanechol Chloride tablet is a DESI (Drug Efficacy Study Implementation) effective drug 
for which there are no known or suspected bioequivalence problems, and as such is rated 
“AA” in the FDA/CDER’s Approved Drug Products with Therapeutic Equivalence 
Evaluations (“Orange Book”). 

 

___________________________________________________________________________ 

 

Analytes to measure (in appropriate biological fluid): Not Applicable 

 

Bioequivalence based on (90% CI): Not Applicable 

 

Waiver request of in-vivo testing: 5 mg, 10 mg, 25 mg and 50 mg pursuant to 21 CFR 
320.22 (c) provided the in-vitro dissolution profiles of your product are comparable to those 
of the reference product. 

 

Dissolution test method and sampling times: 

 

Please note that a Dissolution Methods Database is available to the public at the OGD 
website at http://www.fda.gov/cder/ogd/index.htm. Please find the dissolution information for 
this product at this website. Please conduct comparative dissolution testing on 12 dosage units 
each of all strengths of the test and reference products. Specifications will be determined upon 
review of the application. 


